Bentham Science Logo

Track Your Manuscript:

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 20, 10 Issues, 2021
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access


CNS & Neurological Disorders - Drug Targets , Volume 16 - Number 3

Review Article

Synaptic Plasticity, Dementia and Alzheimer Disease

, 16(3): 220 - 233

Stephen D. Skaper, Laura Facci, Morena Zusso and Pietro Giusti

DOI: 10.2174/1871527316666170113120853

Review Article

Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin

, 16(3): 234 - 243

Zsofia Majlath, Izabella Obal and Laszlo Vecsei

DOI: 10.2174/1871527315666161006104347

Review Article

Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System

, 16(3): 244 - 256

Johannes M. van Noort, Marianna Bugiani and Sandra Amor

DOI: 10.2174/1871527315666161031125317

Review Article

How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications

, 16(3): 266 - 278

George Anderson and Michael Maes

DOI: 10.2174/1871527315666161122144659

Review Article

The Interplay between Cofilin and Phospho-Cofilin: Its Role in Maintaining Blood Brain Barrier Integrity

, 16(3): 279 - 290

Qasim Alhadidi, Muhammad Shahdaat Bin Sayeed and Zahoor A. Shah

DOI: 10.2174/1871527316666170117115040

Review Article

Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease

, 16(3): 291 - 302

Danielle A. Simmons, Frank M. Longo and Stephen M. Massa

DOI: 10.2174/1871527315666161107093047

Review Article

Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy

, 16(3): 303 - 310

Nazrul Islam, Muzaffar Abbas and Shafiqur Rahman

DOI: 10.2174/1871527315666161213104417

Review Article

The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment

, 16(3): 311 - 325

Antonio Leo, Rita Citraro, Rosario Marra, Ernesto Palma, Eugenio Donato Di Paola, Andrew Constanti, Giovambattista De Sarro and Emilio Russo

DOI: 10.2174/1871527315666161104163031

Review Article

Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases

, 16(3): 326 - 338

Yang Sun, Tuo Yang, Rehana K Leak, Jun Chen and Feng Zhang

DOI: 10.2174/1871527316666170102120211

Review Article

Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients

, 16(3): 339 - 345

Claudio Liguori, Enrica Olivola, Mariangela Pierantozzi, Rocco Cerroni, Salvatore Galati, Valentina Saviozzi, Nicola Biagio Mercuri and Alessandro Stefani

DOI: 10.2174/1871527316666161205123123

Research Article

Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling

, 16(3): 346 - 350

Zhiqiang Zhang, Cong Li, Qijia Tan, Caijun Xie, Yanying Yang, Wengang Zhan, Fu Han, Hari Shanker Sharma and Aruna Sharma

DOI: 10.2174/1871527315666160902144513

Research Article

Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach

, 16(3): 351 - 355

Margarita E. Neganova, Sergei G. Klochkov, Ludmila N. Petrova, Elena F. Shevtsova, Svetlana V. Afanasieva, Ekaterina S. Chudinova, Vladimir P. Fisenko, Sergei O. Bachurin, George E. Barreto and Gjumrakch Aliev

DOI: 10.2174/1871527315666161107090525

Research Article

Axotomy Leads to Reduced Calcium Increase and Earlier Termination of CCL2 Release in Spinal Motoneurons with Upregulated Parvalbumin Followed by Decreased Neighboring Microglial Activation

, 16(3): 356 - 367

Melinda Paizs, Roland Patai, Jozsef I. Engelhardt, Zoya Katarova, Izabella Obal and Laszlo Siklos

DOI: 10.2174/1871527315666161223130409


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.



Related Journals

Related eBooks

eBooks Catalog